These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36011250)

  • 1. Towards Better Pharmaceutical Provision in Europe-Who Decides the Future?
    Horgan D; Spanic T; Apostolidis K; Curigliano G; Chorostowska-Wynimko J; Dauben HP; Lal JA; Dziadziuszko R; Mayer-Nicolai C; Kozaric M; Jönsson B; Gutierrez-Ibarluzea I; Fandel MH; Lopert R
    Healthcare (Basel); 2022 Aug; 10(8):. PubMed ID: 36011250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
    Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
    Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Making the Most of Innovation in Personalised Medicine: An EU Strategy for a Faster Bench to Bedside and Beyond Process.
    Horgan D; Lal JA
    Public Health Genomics; 2018; 21(3-4):101-120. PubMed ID: 30947224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The European Innovative Medicines Initiative: Progress to Date.
    Faure JE; Dyląg T; Norstedt I; Matthiessen L
    Pharmaceut Med; 2018; 32(4):243-249. PubMed ID: 30174434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anniversary Oncology Days in Paris.
    Baltaga R
    Exp Oncol; 2023 Dec; 45(3):273-274. PubMed ID: 38186028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European Health Data Space-An Opportunity Now to Grasp the Future of Data-Driven Healthcare.
    Horgan D; Hajduch M; Vrana M; Soderberg J; Hughes N; Omar MI; Lal JA; Kozaric M; Cascini F; Thaler V; Solà-Morales O; Romão M; Destrebecq F; Sky Gross E
    Healthcare (Basel); 2022 Aug; 10(9):. PubMed ID: 36141241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CNS drug development in Europe--past progress and future challenges.
    Nutt DJ; Attridge J
    Neurobiol Dis; 2014 Jan; 61():6-20. PubMed ID: 23685094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating China in the International Consortium for Personalised Medicine: a position paper on innovation and digitalization in Personalized Medicine.
    Beccia F; Di Marcantonio M; Causio FA; Schleicher L; Wang L; Cadeddu C; Ricciardi W; Boccia S
    BMC Public Health; 2024 Feb; 24(1):464. PubMed ID: 38355452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.
    Borg JJ; Aislaitner G; Pirozynski M; Mifsud S
    Drug Saf; 2011 Mar; 34(3):187-97. PubMed ID: 21332243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial Intelligence: Power for Civilisation - and for Better Healthcare.
    Horgan D; Romao M; Morré SA; Kalra D
    Public Health Genomics; 2019; 22(5-6):145-161. PubMed ID: 31838476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Call for More Effective Regulation of Clinical Trials with Advanced Therapy Medicinal Products Consisting of or Containing Genetically Modified Organisms in the European Union.
    Beattie S;
    Hum Gene Ther; 2021 Oct; 32(19-20):997-1003. PubMed ID: 33843251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How Can the EU Beating Cancer Plan Help in Tackling Lung Cancer, Colorectal Cancer, Breast Cancer and Melanoma?
    Horgan D; Baird AM; Middleton M; Mihaylova Z; Van Meerbeeck JP; Vogel-Claussen J; Van Schil PE; Malvehy J; Ascierto PA; Dube F; Zaiac M; Lal JA; Kamińska-Winciorek G; Donia M; André T; Kozaric M; Osterlund P; Dumitrascu DL; Bertolaccini L
    Healthcare (Basel); 2022 Aug; 10(9):. PubMed ID: 36141230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innovation Partnership for a Roadmap on Vaccines in Europe (IPROVE): A vision for the vaccines of tomorrow.
    Medaglini D; De Azero MR; Leroy O; Bietrix F; Denoel P
    Vaccine; 2018 Feb; 36(9):1136-1145. PubMed ID: 29395517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orphan Medicines for Pediatric Use: A Focus on the European Union.
    Bolislis WR; Corriol-Rohou S; Hill-Venning C; Hoogland H; Joos A; King D; Kitcatt V; Le Visage G; Kühler TC
    Clin Ther; 2019 Dec; 41(12):2630-2642. PubMed ID: 31704041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.
    Suleman S; Woliyi A; Woldemichael K; Tushune K; Duchateau L; Degroote A; Vancauwenberghe R; Bracke N; De Spiegeleer B
    Ethiop J Health Sci; 2016 May; 26(3):259-76. PubMed ID: 27358547
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.